Advanced Search

 

Study ID Status Title Patient Level Data
nuc30957 Completed Phase III clinical study of GG714 (Lamivudine) Tablet - A double-blind, placebo-controlled study to investigate the efficacy and safety of Lamivudine 100 mg o.d. vs placebo in subjects with compensated cirrhosis B -
NUC30958 Completed A Phase III Clinical Study of GG714 (Lamivudine) Tablet-A study of extended GG714 treatment for subjects with hepatitis B-related Cirrhosis (long-term study)
NUC40019 Completed An open study to determine the safety and efficacy of lamivudine in subjects with chronic hepatitis B
NUC40021 Completed A Stratified, Partially Randomised (Stratum B only), Double Blind, Multicentre Trial of Lamivudine and Adefovir Dipivoxil Treatment for Patients with Chronic Hepatitis B Who Have Shown Disease Progression by Reaching a Clinical Endpoint
NUC40031 Completed Open study to determine the effect of Lamivudine on liver histology and DNA HBV suppression in patients after seroconversion in HBeAg and with HBsAg present
NUC40032 Completed Pre-emptive Lamivudine and Chemotherapy-induced Hepatitis B Virus Reactivation in Patients with Hematologic Malignancies
NUC40036 Completed An open-label, Phase IV study to examine whether the duration of lamivudine treatment following HBeAg seroconversion affects the durability of the HBeAg seroconversion response in Asian patients.
NUC40040 Completed An Extended, Observational Study in Pediatric Patients with Chronic Hepatitis B Who Have Previously Received Long-Term Lamivudine Treatment
NUCA1004 Completed A Single-Dose Study of GR109714X (3TCTM) in HIV-Infected Patients with Impaired Renal Function
NUCA1006 Completed Bioequivalence of Lamivudine [GR109714X, 3TCTM] 75mg, 100mg, and 300mg Tablets in Asymptomatic HIV-Infected Male Patients
NUCA2002 Completed A Phase I/II Study of 3TC (GR109714X) in Children With HIV Infection
NUCA2005 Completed A phase I/II study to evaluate the safety, toxicity and preliminary efficacy of combinations of lamivudine (3TC), Zidovudine (ZDV) and Didanosine (ddI) in children with HIV infection.
NUCA2006 Completed A Pilot Study to Assess the Safety and Efficacy of Lamivudine During the Course of Liver Transplantation for Patients with Chronic Hepatitis B Infection
NUCA2008 Completed A Continuation Study of Lamivudine in Patients with Chronic Hepatitis B Infection
NUCA2010 Completed Lamivudine Compassionate Use for Patients with Decompensated Liver Injury Secondary to Hepatitis B Infection
NUCA3001 Completed A Randomized, Double-Blind, Multi-center Trial to Compare the Safety and Efficacy of 3TCTM Monotherapy Versus Zidovudine (ZDV) Monotherapy Versus 3TCTM Administered Concurrently with ZDV in the Treatment of HIV-1 Infected Patients who are ZDV-Naïve (?4 weeks) with CD4 Cell Counts of 200-500 cell ...
NUCA3002 Completed A Randomized 3TCTM, ddC Double-Blind (ZDV Open-labeled) Multi-center Trial to Evaluate the Safety and Efficacy of 3TCTM (low dose) Administered Concurrently with Zidovudine (ZDV) versus 3TCTM (high dose) Administered Concurrently with ZDV Versus Dideoxycytidine (ddC) Administered…
NUCA3005 Completed Lamivudine Open-label Protocol for Treatment of Patients with Hepatitis B Viral Infection After Liver Transplantation
NUCA3010 Completed A Study of Lamiviudine or Placebo in Patients with Chronic Hepatitis B Infection Who are Treatment Naive
NUCA3016 Completed A Five Year Final Study Report for NUCA/B3016 - A Long-Term Epidemiologic Study of Subjects Who Have Evidence of Possible Durable Response to Lamivudine in Phase II or Phase III Trials of Lamivudine
NUCA3021 Completed Lamivudine Compassionate Use Treatment Program for Subjects with Three Life-Threatening Forms of Hepatitis B Infection
NUCAB3011 Completed A Placebo Controlled Study of Lamivudine and Intron A in Patients with Chronic Hepatitis B Infection Who are Interferon a Non-Responders
NUCB1002 Completed A Study to Investigate the Pharmacokinetics of Lamivudine (GR109714X) in Patients With Impaired Hepatic Function (Protocol No: C93-015)
NUCB1003 Completed A Study to Investigate the Pharmacokinetics of Lamivudine (GR109714X) Following Oral Dosing in Subjects With Impaired Renal Function
NUCB1004 Completed A study to investigate the comparative bioavailability of two oral formulations of GR109714X (Lamivudine).

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.